Barnett Fung, DPM
Podiatrist · Chicago, ILNPI 1932104718
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Viiv Healthcare Company at 40.3% of the total. Reporting peaked in 2021 at $658 and has fallen 60.2% since, to $262 in 2022.
Across 62 payments — averaging $20.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$522
- AbbVie$167
- Boehringer Ingelheim$157
- Novo Nordisk$141
- Sunovion Pharmaceuticals Inc.$87
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$74
- plus $147 from 5 others
What the payments were for
- Food & beverage$1,294100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 26 | $522 |
| AbbVie | 8 | $167 |
| Boehringer Ingelheim | 7 | $157 |
| Novo Nordisk | 7 | $141 |
| Sunovion Pharmaceuticals Inc. | 6 | $87 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $74 |
| IBSA Pharma Inc. | 3 | $60 |
| Smith+Nephew | 1 | $28 |
| Lilly USA, LLC | 1 | $20 |
| Pfizer | 1 | $20 |
| GRT US Holding, Inc. | 1 | $20 |
How this compares
$1,294 in reported general payments places this provider in the 60th percentile of 409 podiatrist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 20 | $348 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Chicago
- Nathaniel GeorgeChicago$19K
- Walter JacobsenChicago$10K
- David GelbmannChicago$8K
- Leonid BlyuminChicago$6K
- Donna HayesChicago$6K
- Raymond Montoya IiChicago$6K
- Jondelle JenkinsChicago$6K
- Darla ThomasChicago$6K
- Carlos SmithChicago$6K
- Lisa Horn StinsonChicago$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.